Steven Kafka
Chief Executive Officer chez DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Profil
Steven J.
Kafka currently works at DA32 Life Science Tech Acquisition Corp., as Chief Executive Officer, Glympse Bio, Inc., as Director, BigHat Biosciences, Inc., as Director, Rome Therapeutics, Inc., as Director from 2021, ImmuneID, Inc., as Director, Sunbird Bio, Inc., as Director, and Section 32 LLC, as Managing Partner from 2019.
Dr. Kafka also formerly worked at Thrive Earlier Detection Corp., as Executive Chairman & Co-Chief Executive Officer from 2019 to 2021, ArcherDX LLC, as Executive Chairman from 2019 to 2020, Millennium Pharmaceuticals, Inc., as Senior Director-Finance, Forrester Research, Inc., as Research Director, Relay Therapeutics, Inc., as Independent Director from 2018 to 2019, Aileron Therapeutics, Inc., as Chief Financial Officer, VP-Finance & Operations from 2009 to 2011, Infinity Pharmaceuticals, Inc., as Vice President-Finance, Strategic Decisions Group, as Senior Manager-Engagement, Third Rock Ventures LLC, as Partner from 2018 to 2019, and Foundation Medicine, Inc., as President & Chief Operating Officer from 2015 to 2018.
Dr. Kafka received his doctorate degree from Harvard University and undergraduate degree from Stanford University.
Postes actifs de Steven Kafka
| Sociétés | Poste | Début |
|---|---|---|
| DA32 LIFE SCIENCE TECH ACQUISITION CORP. | Chief Executive Officer | 01/04/2021 |
Section 32 LLC
 Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Private Equity Investor | 01/12/2019 |
BigHat Biosciences, Inc.
 BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | Director/Board Member | - |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Director/Board Member | 14/09/2021 |
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Director/Board Member | - |
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Director/Board Member | - |
Sunbird Bio, Inc.
 Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | Director/Board Member | - |
Anciens postes connus de Steven Kafka
| Sociétés | Poste | Fin |
|---|---|---|
Thrive Earlier Detection Corp.
 Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Chief Executive Officer | 01/01/2021 |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Chairman | 01/10/2020 |
| ░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Steven Kafka
| Harvard University | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| FORRESTER RESEARCH, INC. | Commercial Services |
| AILERON THERAPEUTICS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| RELAY THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Strategic Decisions Group
 Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Strategic Decisions Group provides consulting solutions. Its solutions include business strategy, portfolio management and allocation, decision and risk analytics, and organization and decision process design. The company was founded by Ronald A. Howard in 1981 and is headquartered in Palo Alto, CA. | Commercial Services |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Technology Services |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Finance |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Health Technology |
BigHat Biosciences, Inc.
BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | Health Technology |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Health Technology |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Commercial Services |
DA32 Life Science Tech Acquisition Corp.
 DA32 Life Science Tech Acquisition Corp. Financial ConglomeratesFinance DA32 Life Science Tech Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on April 16, 2021 and is headquartered in New York, NY. | Finance |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | Health Technology |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
